Name: MaxCyte, Inc. (MXCT) Financial Statements
Creator: FinSpry

MaxCyte Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

MaxCyte, Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Revenue & Gross Profit
Revenue	38.63	41.29	44.26	33.89	26.17
Cost of Revenue	7.10	4.74	5.10	3.65	2.77
Gross Profit	31.53	36.55	39.16	30.25	23.40
Operating Expenses
Research & Development	22.23	23.82	19.51	15.41	17.73
Selling, General & Administrative	56.35	57.04	44.48	31.68	15.70
Operating Expenses	82.72	84.85	66.52	48.44	34.46
Operating Income	-51.20	-48.30	-27.36	-18.19	-11.06
Other Income/Expense
Interest Income	10.14	10.38	3.92	0.15	0.07
Interest Expense	0.00	0.00	0.13	1.04	-0.46
Other Income/Expense	0.00	0.00	-0.13	-0.65	-0.37
Income
Income Before Tax	-41.06	-37.92	-23.57	-19.08	-11.82
Income Tax Expense	0.00	0.00	0.00	0.00	0.00
Net Income	-41.06	-37.92	-23.57	-19.08	-11.82
Net Income - Continuous Operations	-41.06	-37.92	-23.57	-19.08	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00
EBITDA	-46.41	-43.73	-24.66	-16.61	-10.01
EBIT	-51.20	-48.30	-27.36	-18.04	-11.06
Depreciation & Amortization	4.14	3.99	2.70	1.35	1.05
Earnings Per Share
Basic EPS	-	-	-	-	-
Diluted EPS	-	-	-	-	-
Basic Shares Outstanding	104.85	103.27	101.70	90.62	69.46
Diluted Shares Outstanding	104.85	103.27	101.70	90.62	69.46